CD8A and neoplasm: In addition, the combination of anti-CA19-9 therapy with or without anti-PD-1 significantly enhanced the tumor infiltration of CD8+ T cells and reduced the presence of myeloid-derived suppressor cells (MDSCs), including both polymorphonuclear (PMN)-MDSCs and mononuclear (M)-MDSCs (Figures 3C, D).